Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Graninger, W.
Immunomodulatory therapy improves quality of life with rheumatoid arthritis].
Z Rheumatol. 2010; 69(3):210-212
Doi: 10.1007/s00393-009-0574-8
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Graninger Winfried
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Pain, fatigue as well as functional and social impairments reduce the health-related quality of life in rheumatoid arthritis patients. Using numeric evaluations and qualitative questionnaires, it could be shown in both controlled drugs trials and in practice registries that modern drug therapy achieves an improvement in terms of quality of life (as well as in other patient-related treatment results). However, the improvements often do not achieve even the average quality-of-life levels seen in healthy people.
- Find related publications in this database (using NLM MeSH Indexing)
- Antirheumatic Agents - therapeutic use
- Arthritis, Rheumatoid - drug therapy
- Arthritis, Rheumatoid - psychology
- Humans -
- Immunologic Factors - therapeutic use
- Immunosuppressive Agents - therapeutic use
- Methotrexate - therapeutic use
- Patient Satisfaction -
- Psychometrics -
- Quality of Life - psychology
- Randomized Controlled Trials as Topic -
- Reproducibility of Results -
- Surveys and Questionnaires -
- Find related publications in this database (Keywords)
- Biologics
- Quality-of-life measurement
- Functional impairment
- Satisfaction with life
- Disease activity